ES2355265T3 - Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo. - Google Patents

Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo. Download PDF

Info

Publication number: ES2355265T3
Authority: ES; Spain
Prior art keywords: ngb; antibody; elisa kit; protein; antigen
Prior art date: 2005-04-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES05745128T

Other languages

English (en)

Spanish (es)

Inventor

Lihong Wang

Tingfang Chen

Aijia Shang

Yan Gao

Chennang Zhang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BEIJING THREEMAN MEDICINE SCIENCE AND TECHNOLOGY Ltd Co

Institute of Radiation Medicine of CAMMS

Original Assignee

BEIJING THREEMAN MEDICINE SCIENCE AND TECHNOLOGY Ltd Co

Institute of Radiation Medicine of CAMMS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-30

Filing date

2005-04-30

Publication date

2011-03-24

2005-04-30 Application filed by BEIJING THREEMAN MEDICINE SCIENCE AND TECHNOLOGY Ltd Co, Institute of Radiation Medicine of CAMMS filed Critical BEIJING THREEMAN MEDICINE SCIENCE AND TECHNOLOGY Ltd Co

2011-03-24 Application granted granted Critical

2011-03-24 Publication of ES2355265T3 publication Critical patent/ES2355265T3/es

2025-04-30 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108090000790 Enzymes Proteins 0.000 title claims abstract description 13
102000004190 Enzymes Human genes 0.000 title claims abstract description 13
238000001514 detection method Methods 0.000 title description 7
210000002966 serum Anatomy 0.000 claims abstract description 27
238000008157 ELISA kit Methods 0.000 claims abstract description 24
101001023815 Homo sapiens Neuroglobin Proteins 0.000 claims abstract description 24
230000014509 gene expression Effects 0.000 claims abstract description 17
239000000427 antigen Substances 0.000 claims abstract description 16
102000036639 antigens Human genes 0.000 claims abstract description 16
108091007433 antigens Proteins 0.000 claims abstract description 16
241000699670 Mus sp. Species 0.000 claims abstract description 15
210000004408 hybridoma Anatomy 0.000 claims abstract description 12
230000003053 immunization Effects 0.000 claims abstract description 12
239000013604 expression vector Substances 0.000 claims abstract description 10
230000009465 prokaryotic expression Effects 0.000 claims abstract description 8
230000007910 cell fusion Effects 0.000 claims abstract description 7
241001465754 Metazoa Species 0.000 claims abstract description 6
239000002299 complementary DNA Substances 0.000 claims abstract description 6
238000012258 culturing Methods 0.000 claims abstract description 6
241001131785 Escherichia coli HB101 Species 0.000 claims abstract description 5
238000005571 anion exchange chromatography Methods 0.000 claims abstract description 4
238000002523 gelfiltration Methods 0.000 claims abstract description 4
230000000638 stimulation Effects 0.000 claims abstract description 3
239000001963 growth medium Substances 0.000 claims description 15
241000588724 Escherichia coli Species 0.000 claims description 6
206010008118 cerebral infarction Diseases 0.000 claims description 6
239000003153 chemical reaction reagent Substances 0.000 claims description 6
238000011161 development Methods 0.000 claims description 6
238000003756 stirring Methods 0.000 claims description 6
208000026106 cerebrovascular disease Diseases 0.000 claims description 5
208000024827 Alzheimer disease Diseases 0.000 claims description 4
241000283707 Capra Species 0.000 claims description 4
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 4
229960000723 ampicillin Drugs 0.000 claims description 4
238000003759 clinical diagnosis Methods 0.000 claims description 4
206010039966 Senile dementia Diseases 0.000 claims description 3
208000030886 Traumatic Brain injury Diseases 0.000 claims description 3
230000009529 traumatic brain injury Effects 0.000 claims description 3
108060003951 Immunoglobulin Proteins 0.000 claims description 2
102000018358 immunoglobulin Human genes 0.000 claims description 2
238000002372 labelling Methods 0.000 claims description 2
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims 1
102000013274 Neuroglobin Human genes 0.000 description 65
108010026092 Neuroglobin Proteins 0.000 description 65
210000004027 cell Anatomy 0.000 description 27
108090000623 proteins and genes Proteins 0.000 description 25
102000004169 proteins and genes Human genes 0.000 description 24
235000018102 proteins Nutrition 0.000 description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
239000000872 buffer Substances 0.000 description 16
208000028867 ischemia Diseases 0.000 description 16
238000004458 analytical method Methods 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
238000000034 method Methods 0.000 description 14
239000006228 supernatant Substances 0.000 description 13
239000011534 wash buffer Substances 0.000 description 13
210000004556 brain Anatomy 0.000 description 12
241000894006 Bacteria Species 0.000 description 11
239000007984 Tris EDTA buffer Substances 0.000 description 11
239000008363 phosphate buffer Substances 0.000 description 11
239000000047 product Substances 0.000 description 11
241000283973 Oryctolagus cuniculus Species 0.000 description 10
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
238000010586 diagram Methods 0.000 description 10
238000005406 washing Methods 0.000 description 10
241000699694 Gerbillinae Species 0.000 description 9
102100030856 Myoglobin Human genes 0.000 description 9
108010062374 Myoglobin Proteins 0.000 description 9
229920001213 Polysorbate 20 Polymers 0.000 description 9
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 9
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 9
239000013598 vector Substances 0.000 description 9
230000000903 blocking effect Effects 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 8
238000003119 immunoblot Methods 0.000 description 8
239000012528 membrane Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
239000000243 solution Substances 0.000 description 7
108020004414 DNA Proteins 0.000 description 6
239000005018 casein Substances 0.000 description 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
235000021240 caseins Nutrition 0.000 description 6
230000008859 change Effects 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
238000009826 distribution Methods 0.000 description 6
239000012634 fragment Substances 0.000 description 6
238000002649 immunization Methods 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
241000700159 Rattus Species 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
239000004202 carbamide Substances 0.000 description 5
235000013877 carbamide Nutrition 0.000 description 5
239000011248 coating agent Substances 0.000 description 5
238000000576 coating method Methods 0.000 description 5
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 5
102000055898 human NGB Human genes 0.000 description 5
239000007928 intraperitoneal injection Substances 0.000 description 5
239000013642 negative control Substances 0.000 description 5
210000002569 neuron Anatomy 0.000 description 5
230000010410 reperfusion Effects 0.000 description 5
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 5
206010003445 Ascites Diseases 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
238000010276 construction Methods 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
230000000405 serological effect Effects 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
206010063837 Reperfusion injury Diseases 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
125000003275 alpha amino acid group Chemical group 0.000 description 3
208000029028 brain injury Diseases 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000009089 cytolysis Effects 0.000 description 3
239000013024 dilution buffer Substances 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
239000003480 eluent Substances 0.000 description 3
239000006167 equilibration buffer Substances 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
102000018146 globin Human genes 0.000 description 3
108060003196 globin Proteins 0.000 description 3
210000001320 hippocampus Anatomy 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
230000036046 immunoreaction Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000003902 lesion Effects 0.000 description 3
239000003550 marker Substances 0.000 description 3
210000000653 nervous system Anatomy 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
239000004017 serum-free culture medium Substances 0.000 description 3
235000011149 sulphuric acid Nutrition 0.000 description 3
239000000725 suspension Substances 0.000 description 3
208000019553 vascular disease Diseases 0.000 description 3
108091026890 Coding region Proteins 0.000 description 2
102000001554 Hemoglobins Human genes 0.000 description 2
108010054147 Hemoglobins Proteins 0.000 description 2
101100240471 Homo sapiens NGB gene Proteins 0.000 description 2
101150045580 NGB gene Proteins 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
210000001015 abdomen Anatomy 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000006931 brain damage Effects 0.000 description 2
231100000874 brain damage Toxicity 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
229910000397 disodium phosphate Inorganic materials 0.000 description 2
235000019800 disodium phosphate Nutrition 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000011068 loading method Methods 0.000 description 2
210000004165 myocardium Anatomy 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
238000009210 therapy by ultrasound Methods 0.000 description 2
238000002604 ultrasonography Methods 0.000 description 2
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
HYCKBFLTZGORKA-HNPMAXIBSA-N 3,7-dihydropurin-6-one;1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC=NC2=C1NC=N2.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 HYCKBFLTZGORKA-HNPMAXIBSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
201000006474 Brain Ischemia Diseases 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
206010008120 Cerebral ischaemia Diseases 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
239000007836 KH2PO4 Substances 0.000 description 1
238000012449 Kunming mouse Methods 0.000 description 1
102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
239000012564 Q sepharose fast flow resin Substances 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
208000020560 abdominal swelling Diseases 0.000 description 1
230000004913 activation Effects 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000011091 antibody purification Methods 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000009534 blood test Methods 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
210000003710 cerebral cortex Anatomy 0.000 description 1
230000037029 cross reaction Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000012154 double-distilled water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
108010036302 hemoglobin AS Proteins 0.000 description 1
230000000971 hippocampal effect Effects 0.000 description 1
238000013095 identification testing Methods 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
208000012947 ischemia reperfusion injury Diseases 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000002241 neurite Anatomy 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
210000004303 peritoneum Anatomy 0.000 description 1
239000013641 positive control Substances 0.000 description 1
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
239000012474 protein marker Substances 0.000 description 1
210000002763 pyramidal cell Anatomy 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
239000012898 sample dilution Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017550 sodium carbonate Nutrition 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000009331 sowing Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
238000002305 strong-anion-exchange chromatography Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000010257 thawing Methods 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
239000012224 working solution Substances 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/805—Haemoglobins; Myoglobins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

ES05745128T 2005-04-30 2005-04-30 Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo. Expired - Lifetime ES2355265T3 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/CN2005/000613 WO2006116898A1 (en)	2005-04-30	2005-04-30	A neuroglobin enzyme-linked immunodetection kit and the use of it

Publications (1)

Publication Number	Publication Date
ES2355265T3 true ES2355265T3 (es)	2011-03-24

Family

ID=37307582

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES05745128T Expired - Lifetime ES2355265T3 (es)	2005-04-30	2005-04-30	Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo.

Country Status (10)

Country	Link
US (1)	US20100028917A1 (de)
EP (1)	EP1879029B8 (de)
JP (1)	JP4714265B2 (de)
CN (1)	CN101166975A (de)
AT (1)	ATE491949T1 (de)
DE (1)	DE602005025414D1 (de)
DK (1)	DK1879029T3 (de)
ES (1)	ES2355265T3 (de)
PL (1)	PL1879029T3 (de)
WO (1)	WO2006116898A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102175682B (zh) *	2010-03-08	2013-02-20	中国人民解放军军事医学科学院放射与辐射医学研究所	重组人源脑红蛋白的生物活性检测方法及其用途
SG11201606940SA (en) *	2012-11-20	2016-10-28	Stochastic Simulation Ltd	Method and system for characterising subsurface reservoirs
CN106771234A (zh) *	2016-12-05	2017-05-31	广州华弘生物科技有限公司	一种利用双抗夹心法定量测定脑红蛋白的方法及其应用
CN111892653A (zh) *	2019-07-03	2020-11-06	长春恒晓生物科技有限责任公司	制备粘病毒抗性蛋白1抗体及建立检测mx1方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10009119A1 (de) *	2000-02-26	2001-11-22	Univ Mainz Johannes Gutenberg	Vertebraten Globin
US6916626B1 (en) *	2001-04-25	2005-07-12	Rockeby Biomed Ltd.	Detection of Candida
WO2003040332A2 (en) *	2001-11-06	2003-05-15	Buck Institute	Neuroglobin is up-regulated by and protects neuronsfrom hypoxic-ischemic injury

2005
- 2005-04-30 ES ES05745128T patent/ES2355265T3/es not_active Expired - Lifetime
- 2005-04-30 DE DE602005025414T patent/DE602005025414D1/de not_active Expired - Lifetime
- 2005-04-30 US US11/913,134 patent/US20100028917A1/en not_active Abandoned
- 2005-04-30 DK DK05745128.8T patent/DK1879029T3/da active
- 2005-04-30 EP EP05745128A patent/EP1879029B8/de not_active Expired - Lifetime
- 2005-04-30 WO PCT/CN2005/000613 patent/WO2006116898A1/zh not_active Ceased
- 2005-04-30 CN CNA2005800496203A patent/CN101166975A/zh active Pending
- 2005-04-30 JP JP2008508048A patent/JP4714265B2/ja not_active Expired - Fee Related
- 2005-04-30 PL PL05745128T patent/PL1879029T3/pl unknown
- 2005-04-30 AT AT05745128T patent/ATE491949T1/de active

Also Published As

Publication number	Publication date
JP4714265B2 (ja)	2011-06-29
CN101166975A (zh)	2008-04-23
EP1879029B8 (de)	2011-09-21
WO2006116898A1 (en)	2006-11-09
EP1879029B1 (de)	2010-12-15
DE602005025414D1 (de)	2011-01-27
PL1879029T3 (pl)	2011-05-31
EP1879029A1 (de)	2008-01-16
EP1879029A4 (de)	2009-01-28
DK1879029T3 (da)	2011-03-21
US20100028917A1 (en)	2010-02-04
ATE491949T1 (de)	2011-01-15
JP2008541008A (ja)	2008-11-20

Publication	Publication Date	Title
JP5731109B2 (ja)	2015-06-10	疎水性ペプチドに対する抗体の製造方法
KR100328112B1 (ko)	2002-07-02	류마토이드관절염병원관련관절염성펩티드에대항하는면역보호유도에유용한백신조성물과방법
WO2016104439A1 (ja)	2016-06-30	抗活性型ｇｉｐ抗体
JP2710645B2 (ja)	1998-02-10	ｓｎＲＮＰ−Ａ抗原及びそのフラグメント
ES2355265T3 (es)	2011-03-24	Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo.
CN109142738A (zh)	2019-01-04	Ecm1作为血清学检测肝纤维化的标志物及其应用
JP2815582B2 (ja)	1998-10-27	原発性胆汁肝硬変自己抗原
CN104845981A (zh)	2015-08-19	田鼠巴贝虫Bm1524抗原及其应用
CN101357227B (zh)	2011-07-27	老年性痴呆重组腺病毒基因疫苗及其制备方法
CN104031149B (zh)	2017-07-07	抗pml蛋白核定位信号抗体的制备及其在apl诊断中的应用
JP2019501964A (ja)	2019-01-24	ポリペプチド化合物、並びにその調製方法及び適用
CN114316057B (zh)	2022-05-10	一种靶向线粒体外膜转位因子复合体tom20亚基的纳米抗体及其应用
CN117362424A (zh)	2024-01-09	一种抗幽门螺旋杆菌单克隆抗体及其应用
CN110133290B (zh)	2021-02-26	一种诊断犬恶丝虫病的elisa试剂盒
CN115894670A (zh)	2023-04-04	一种非洲猪瘟病毒CD2v蛋白特异性抗体及其应用
ES2392312T3 (es)	2012-12-07	Nuevo marcador del cáncer de hígado
JP4651495B2 (ja)	2011-03-16	Ｉｓｇ１５タンパク質と特異的に反応するモノクローナル抗体及びそれを産生するハイブリドーマ並びに癌およびウイルス感染の検出方法
CN114524870A (zh)	2022-05-24	源自于ssx2抗原的短肽
CN102071205B (zh)	2012-05-23	华支睾吸虫的特异性抗原及用途
WO1989008118A1 (en)	1989-09-08	Synthetic scm-active cancer recognition peptides
ES2528738T3 (es)	2015-02-12	Método para potenciar la eficacia de una preparación de un anticuerpo monoclonal
CN120209130A (zh)	2025-06-27	抗pinp单克隆抗体或其抗原结合片段及其应用
CN119019514A (zh)	2024-11-26	一种具有免疫原性的呼吸道合胞病毒（rsv）多肽
CA1341536C (en)	2007-07-24	Transforming growth factor peptides
RU2396277C1 (ru)	2010-08-10	Пептид, стимулирующий образование специфических антител, выявляющих сурвивин в опухолевых тканях